Patent details

Basic Information

Publication number:

EP1697360

PCT Application Number:

PCT/SE/2004/001909

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP048090823

PCT Publication Number:

WO/2005/058895

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

NOVEL CRYSTALLINE FORMS OF 2, 3 DIMETHYL-8- (2, 6-DIMETHYLBENZYLAMINO) -N-HYDROXYETHYL-IMIDAZO 1, 2-A PYRIDINE-6-CARBOXAMIDE MESYLATE SALT.

French Title of Invention:

FORMES CRISTALLINES DE SEL MESYLATE DE 2, 3 DIMETHYL-8- (2, 6-DIMETHYLBENZYLAMINO) -N-HYDROXYETHYL-IMIDAZO 1, 2-A¨ PYRIDINE-6-CARBOXAMIDE.

German Title of Invention:

NEUE KRISTALLINE FORMEN VON 2,3-DIMETHYL-8-(2,6-DIMETHYLBENZYLAMINO)-N-HYDROXYETHYLIMIDAZOÖ1,2-AÜPYRIDIN-6-CARBONSÄUREAMIDMESYLATSALZ

SPC Number:

Dates

Filing date:

16/12/2004

Grant date:

23/02/2011

EP Publication Date:

23/02/2011

PCT Publication Date:

30/06/2005

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/09/2006

EP B1 Publication Date:

23/02/2011

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

16/12/2011

Expiration date:

16/12/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/12/2004

 

 

Name:

AstraZeneca AB

Address:

-, 151 85 Södertälje, Sweden (SE)

Inventor

1

Name:

NORDBERG Peter

Address:

Sweden (SE)

2

Name:

PETTERSSON Ursula

Address:

Sweden (SE)

3

Name:

LINDKVIST Maria

Address:

Sweden (SE)

4

Name:

LILLJEQUIST Lars

Address:

Sweden (SE)

5

Name:

SEBHATU Tesfai

Address:

Sweden (SE)

Priority

Priority Number:

0303451

Priority Date:

18/12/2003

Priority Country:

Sweden (SE)

Classification

Main IPC Class:

C07D 471/04;

Filing date	Document type	Number of pages